Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Mold detection device from Universal Detection Technology

Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced today that it is expanding its product catalogue to include a consumer-ready kit for the detection of black mold.

4 Nov 2009

Study compares neighborhoods' walkability with local levels of air pollution

A new study compares neighborhoods' walkability (degree of ease for walking) with local levels of air pollution and finds that some neighborhoods might be good for walking, but have poor air quality. Researchers involved in the study include University of Minnesota faculty member Julian Marshall and University of British Columbia faculty Michael Brauer and Lawrence Frank.

4 Nov 2009

Aerocrine, PSEC enters into a long-term development agreement

Aerocrine AB today announced that Aerocrine and Panasonic Shikoku Electronics, CO., LTD (PSEC) have entered into a long-term agreement to develop, manufacture and market new generation products for airway inflammation monitoring using exhaled nitric oxide.

4 Nov 2009

Five-year old Pennsylvanian boy dies of H1N1 flu complications

The Department of Health today confirmed that a five-year old Adams County boy died on Oct. 31 as a result of complications from H1N1 flu. This is Pennsylvania's first pediatric death associated with H1N1.

4 Nov 2009

Report addressing the connection between student health and academic achievement unveiled

In an effort to ensure that student health plays a central role in California’s education reform agenda, the state’s largest private health foundation today unveiled the first report produced from a multi-year project addressing the connection between student health and academic achievement.

4 Nov 2009

Study sheds light on the rise in childhood asthma in developed countries

A University of Adelaide study may have shed light on the rise in childhood asthma in developed countries like Australia in recent decades.

4 Nov 2009

Breastfeeding: ADA position paper details health benefits for both infants and mothers

The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.

4 Nov 2009

First responders at WTC attacks twice likely to suffer from asthma

First responders who were exposed to caustic dust and toxic pollutants following the 2001 World Trade Center (WTC) terrorist attacks suffer from asthma at more than twice the rate of the general U.S. population, according to data presented today by Mount Sinai School of Medicine researchers at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), in San Diego.

3 Nov 2009

Aerovance enrolls 540 patients in Phase 2b Aerovant clinical trial

Aerovance Inc. today announced it has completed patient enrollment in a Phase 2b clinical trial of the inhaled dry powder formulation of Aerovant for the treatment of uncontrolled asthma. Top-line results are expected by the second quarter of 2010.

3 Nov 2009

Rigel Pharmaceuticals announces financial results for the third quarter of 2009

Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

3 Nov 2009

Raycop's anti-bacterial vacuum cleaning system with UVC technology kills the H1N1 virus

Raycop, the first handheld anti-bacterial vacuum cleaning system and part of the Earlex® brands, offers a proven way to fight the H1N1 virus in the home with its UVC technology. The vac's effects against the virus have been independently tested by a leading international laboratory in August.

3 Nov 2009

Half of American children including 90% black children will use food stamps, says study

Nearly half of American children - including 90 percent of black children and 90 percent of children who spend their childhoods in single-parent households - will eat meals paid for by food stamps at some point during childhood, reports a Cornell researcher.

3 Nov 2009

Schering-Plough's Phase III study of Grass Allergy Immunotherapy meets primary endpoint

Schering-Plough Corporation today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy and providing sustained prevention of allergy symptoms, treating both the symptoms and the underlying cause of the disease.

3 Nov 2009

Ligand Pharmaceuticals amends license agreement with Exelixis

Ligand Pharmaceuticals Incorporated has amended its license agreement with Exelixis, Inc. as a result of which Ligand is now entitled to receive royalties on net sales of future products from a mineralocorticoid receptor program and a one-time $75,000 payment for providing access to certain patent rights.

2 Nov 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Pulmatrix raises $30.2 million through Series B financing

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has secured $30.2 million in Series B financing. ARCH Venture Partners and Novartis Bioventures Fund co-led the round with participation from existing investors Polaris Venture Partners and 5AM Ventures.

2 Nov 2009

Colgate-Palmolive reaches ‘100 Million Smiles’ goal with its oral health education program

Colgate-Palmolive Company, the world leader in oral care, announced this week that it has reached 100 million children in the United States, providing free dental screenings, oral health education and treatment referrals as part of its ongoing national education program Colgate Bright Smiles, Bright Futures®.

31 Oct 2009

Four abstracts on RSV and influenza prevention in pediatric health to be presented

MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health.

31 Oct 2009

Avicenna's work on respiratory diseases highlighted in SAGE journal

For pulmonary ailments, certain mediaeval physicians had a useful medical textbook on hand offering detailed information remarkably similar to those a modern doctor might use today. One of the fathers of medicine, the great Persian scholar Avicenna left a wealth of information in his many works. Iranian academics dust off one of these in an article published today in the SAGE journal Therapeutic Advances in Respiratory Disease, sharing in English details of Avicenna's work that still fascinate both physicians and historians of medicine alike.

30 Oct 2009

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease.

30 Oct 2009

Asthma News and Research

Further Reading

Mold detection device from Universal Detection Technology

Study compares neighborhoods' walkability with local levels of air pollution

Aerocrine, PSEC enters into a long-term development agreement

Five-year old Pennsylvanian boy dies of H1N1 flu complications

Report addressing the connection between student health and academic achievement unveiled

Study sheds light on the rise in childhood asthma in developed countries

Breastfeeding: ADA position paper details health benefits for both infants and mothers

First responders at WTC attacks twice likely to suffer from asthma

Aerovance enrolls 540 patients in Phase 2b Aerovant clinical trial

Rigel Pharmaceuticals announces financial results for the third quarter of 2009

Raycop's anti-bacterial vacuum cleaning system with UVC technology kills the H1N1 virus

Half of American children including 90% black children will use food stamps, says study

Schering-Plough's Phase III study of Grass Allergy Immunotherapy meets primary endpoint

Ligand Pharmaceuticals amends license agreement with Exelixis

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix raises $30.2 million through Series B financing

Colgate-Palmolive reaches ‘100 Million Smiles’ goal with its oral health education program

Four abstracts on RSV and influenza prevention in pediatric health to be presented

Avicenna's work on respiratory diseases highlighted in SAGE journal

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News